ArisGlobal Signs Agreement to Acquire Amplexor Life Sciences

(ArisGlobal: Miami; Amplexor Life Sciences: Novo Mesto, Slovenia) -- ArisGlobal, a leading provider of life sciences software designed to automate core drug development functions with its end-to-end technology platform LifeSphere, has acquired Amplexor Life Sciences (LS), a global provider of regulatory, quality, and safety software solutions, serving and trusted by pharmaceutical, biotechnology, and medical device companies.  

The integration of the regulatory product lines will bring a distinct set of benefits to customers. LifeSphere users can now gain access to enhanced publishing and labeling capabilities, in addition to a robust quality management system (QMS) from Amplexor LS.  Amplexor LS’s regulatory customers can now connect to even wider functionality through ArisGlobal’s market-leading LifeSphere platform, including access to state-of-the-art safety, medical affairs, and clinical solutions.  

This combined product ecosystem provides a new opportunity for life sciences companies, bringing together best-in-breed solutions to form a cohesive solution serving customers’ regulatory needs. It also represents many years of industry expertise, software innovation, and customer excellence from ArisGlobal and Amplexor Life Sciences. This move accelerates both companies’ road maps and increases efficiency in bringing new therapies to the market.  

 “For many years, ArisGlobal has been focused on building a regulatory platform that provides a market-leading, comprehensive set of products, and streamlines processes supporting collaboration across distributed teams while adhering to extensive and evolving global regulatory requirements,” says Mike Gordon, chief executive officer at ArisGlobal. “By combining our core functionalities, we are elevating our end-to-end regulatory capabilities to enhance our customers’ journey.”

“Amplexor Life Sciences has always sought to provide their customers with operational excellence in global compliance, and this new chapter of our products within the LifeSphere regulatory platform will continue to do that,” says Elvis Paćelat, executive vice president at Amplexor LS. “We are excited to join forces with ArisGlobal, which has been an innovator in the life sciences space for several decades, to provide the market with a full scope of products designed to make regulatory processes a connected, cloud-based, and compliant experience.”    

“The vision and objectives of ArisGlobal and Amplexor LS are aligned,” says Jim Hilferty, assistant vice president and head of regulatory products at ArisGlobal. “We’re confident that bringing our organizations together will serve as a catalyst for innovation to benefit life sciences, and allow us to deliver the most intelligent, connected, and comprehensive platform available to the regulatory community.”

Both companies have been supporting R&D processes through technology for decades, with offices throughout Europe, the United States, India, and the Asian-Pacifiic region.   

The integration is subject to customary government approvals that are expected to be completed during the next 60 days. Further information will be made available on the combined solution. 

For more information, visit arisglobal.com and amplexorlifesciences.com.

About The Author